Does Overall Treatment Time Impact Toxicity and Clinical Outcomes After Magnetic Resonance Imaging-Guided Stereotactic Body Radiotherapy to the Prostate? An evaluation of the Multi-OutcoMe EvaluatioN of radiation Therapy Using the MR-Linac Repository

This study suggests that OTT, generally between 8 and 18 days, in five-fraction MRgRT for prostate cancer does not affect GU and GI toxicity, QoL and PSA control. Clinicians should consider discussing OTT with patients as this will facilitate treating patients to the time frame that suits them best, reducing the impact of treatment on their QoL, whilst also allowing flexibility for busy departments.